Literature DB >> 21428770

Genomics and drug response.

Liewei Wang1, Howard L McLeod, Richard M Weinshilboum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21428770      PMCID： PMC3184612          DOI： 10.1056/NEJMra1010600

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  70 in total

1.  Multiple personal genomes await.

Authors:  J Craig Venter
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

2.  Has the revolution arrived?

Authors:  Francis Collins
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

3.  The human genome at ten.

Authors: 
Journal:  Nature       Date:  2010-04-01       Impact factor: 49.962

4.  Pharmacogenetics of coumarinic oral anticoagulants.

Authors:  Vangelis G Manolopoulos; Georgia Ragia; Anna Tavridou
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

5.  Ten years on--the human genome and medicine.

Authors:  Harold Varmus
Journal:  N Engl J Med       Date:  2010-05-27       Impact factor: 91.245

Review 6.  Genomic medicine--an updated primer.

Authors:  W Gregory Feero; Alan E Guttmacher; Francis S Collins
Journal:  N Engl J Med       Date:  2010-05-27       Impact factor: 91.245

Review 7.  Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer.

Authors:  Rachel A Freedman; Eric P Winer
Journal:  Breast       Date:  2010-01-19       Impact factor: 4.380

8.  Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.

Authors:  Hersh Sagreiya; Hersh Sagrieya; Caroline Berube; Alice Wen; Ramesh Ramakrishnan; Alain Mir; Amy Hamilton; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-07       Impact factor: 2.089

Review 9.  Adjuvant aromatase inhibitor therapy: outcomes and safety.

Authors:  Wolfgang Janni; Philip Hepp
Journal:  Cancer Treat Rev       Date:  2010-02-04       Impact factor: 12.111

10.  IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors:  Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330
View more
  212 in total

1.  Prediction of drug response and safety in clinical practice.

Authors:  Andrew A Monte; Kennon J Heard; Vasilis Vasiliou
Journal:  J Med Toxicol       Date:  2012-03

2.  The impact of pharmacogenomics on the management of cardiac disease.

Authors:  N L Pereira; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2011-08-10       Impact factor: 6.875

3.  Advanced molecular biologic techniques in toxicologic disease.

Authors:  Jeanine Ward; Gyongyi Szabo; David McManus; Edward Boyer
Journal:  J Med Toxicol       Date:  2011-12

Review 4.  The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors:  Michael Camilleri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

5.  Multilevel research and the challenges of implementing genomic medicine.

Authors:  Muin J Khoury; Ralph J Coates; Mary L Fennell; Russell E Glasgow; Maren T Scheuner; Sheri D Schully; Marc S Williams; Steven B Clauser
Journal:  J Natl Cancer Inst Monogr       Date:  2012-05

Review 6.  Genetics of peripheral artery disease.

Authors:  Nicholas J Leeper; Iftikhar J Kullo; John P Cooke
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

7.  Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.

Authors:  Najmeh Ahangari; Mohammad Doosti; Majid Ghayour Mobarhan; Amirhossein Sahebkar; Gordon A Ferns; Alireza Pasdar
Journal:  Ann Med       Date:  2020-08-24       Impact factor: 4.709

8.  Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset.

Authors:  Adam S Gordon; Holly K Tabor; Andrew D Johnson; Beverly M Snively; Themistocles L Assimes; Paul L Auer; John P A Ioannidis; Ulrike Peters; Jennifer G Robinson; Lara E Sucheston; Danxin Wang; Nona Sotoodehnia; Jerome I Rotter; Bruce M Psaty; Rebecca D Jackson; David M Herrington; Christopher J O'Donnell; Alexander P Reiner; Stephen S Rich; Mark J Rieder; Michael J Bamshad; Deborah A Nickerson
Journal:  Hum Mol Genet       Date:  2013-11-26       Impact factor: 6.150

9.  Psychiatric Pharmacogenomics: How Close Are We?

Authors:  Matthew E Hirschtritt; Aaron D Besterman; David A Ross
Journal:  Biol Psychiatry       Date:  2016-08-11       Impact factor: 13.382

Review 10.  Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.

Authors:  Brian C Jensen; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2013-01       Impact factor: 2.533
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.